AKT inhibitors in research and application

Bookmark and Share
Published: 25 Apr 2018
Views: 4334
Dr Brian Schwartz - ArQule, Burlington, USA

Dr Brian Schwartz talks to ecancer at AACR 2018 about the latest developments from ArQule.

He specifically discusses the improvement of their AKT inhibitors after the last few years and future prospects.